Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Classical hematology 1

Conditions

Thrombocytopenia 14Leukemia, Myeloid, Acute 5Leukemia 3Jacobs syndrome 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Chemotherapy-induced Thrombocytopenia 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Gemcitabine 2fludarabine phosphate 1eltrombopag 1SRA737 1Radiotherapy 1Methylprednisolone 1Melphalan 1Enoxaparin 1Cyclophosphamide 1Cisplatin 1Busulfan 1Aspirin 1Antilymphocyte Serum 1Acupuncture Therapy 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × eltrombopag × Classical hematology × Clear all
NCT00358540 2017-11-13

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

GlaxoSmithKline

Phase 1 Completed
18 enrolled
Classical hematologySarcoma

Sarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡